These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010 [TBL] [Abstract][Full Text] [Related]
28. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy. Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934 [TBL] [Abstract][Full Text] [Related]
29. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study. Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171 [TBL] [Abstract][Full Text] [Related]
30. Tiagabine in clinical practice: effects on seizure control and behavior. Vossler DG; Morris GL; Harden CL; Montouris G; Faught E; Kanner AM; Fix A; French JA; Epilepsy Behav; 2013 Aug; 28(2):211-6. PubMed ID: 23770680 [TBL] [Abstract][Full Text] [Related]
32. Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy. de Borchgrave V; Lienard F; Willemart T; van Rijckevorsel K Epilepsy Behav; 2003 Jun; 4(3):326-37. PubMed ID: 12791336 [TBL] [Abstract][Full Text] [Related]
33. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Eckardt KM; Steinhoff BJ Epilepsia; 1998 Jun; 39(6):671-4. PubMed ID: 9637612 [TBL] [Abstract][Full Text] [Related]
35. [Long-term safety of using tiagabine in epilepsy]. Kozik A Neurol Neurochir Pol; 2000; 34 Suppl 7():17-22; discussion 22-3. PubMed ID: 11253488 [TBL] [Abstract][Full Text] [Related]
36. [Characteristics and indications of tiagabine]. Casas-Fernández C; Domingo-Jiménez R Rev Neurol; 2002 Sep; 35 Suppl 1():S96-S100. PubMed ID: 12373661 [TBL] [Abstract][Full Text] [Related]
37. Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin. Hogan RE; Bertrand ME; Deaton RL; Sommerville KW Epilepsy Res; 2000 Aug; 41(1):23-8. PubMed ID: 10924865 [TBL] [Abstract][Full Text] [Related]
38. Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy. Vinton A; Kornberg AJ; Cowley M; Matkovic Z; Kilpatrick C; O'Brien TJ J Clin Neurosci; 2005 Feb; 12(2):128-33. PubMed ID: 15749411 [TBL] [Abstract][Full Text] [Related]
39. Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures. Borowicz KK; Zadrozniak M; Luszczki JJ; Czuczwar SJ J Neural Transm (Vienna); 2008 May; 115(5):661-7. PubMed ID: 18193378 [TBL] [Abstract][Full Text] [Related]
40. [Tiagabine in drug-resistant epilepsy in children: preliminary study]. Wendorff J; Popielarczyk M; Zubiel M; Sokołowska D Neurol Neurochir Pol; 2000; 34 Suppl 1():221-4. PubMed ID: 10768162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]